Company intelligence / Profile preview
Metaphore Biotechnologies
Cambridge, Massachusetts, United Statesmetaphorebio.com ↗
- Ownership
- Private
- Employees
- ~40
- Development stage
- Other
01
Overview
Metaphore Biotechnologies is advancing a broad preclinical pipeline using its proprietary MIMIC™ platform, which leverages machine learning and molecular mimicry to create novel therapeutics targeting autoimmune, metabolic, and oncology indications. No clinical results have been reported yet.
- Therapeutic areas
- Metabolic DisordersOncologyImmunology
- Modalities
- ProteinAntibodySmall molecule
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Novo Nordisk – partnership to develop up to two advanced obesity management treatments using the MIMIC™ platform. Novo Nordisk will advance these into clinical studies if successful.Flagship Pioneering’s Pioneering Medicines unit – joint R&D activities with internal Flagship resources.
Beyond the preview
Go deeper on Metaphore Biotechnologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Metaphore Biotechnologies.